home All News open_in_new Full Article

Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin

Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause and is associated with very high burden of disease due to severe itch, sleep deprivation and mental distress1 Galderma’s phase II study builds on emerging research that reinforces the role of IL-31 – a neuroimmune cytokine that […]


today 8 d. ago attach_file Science

attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Culture
attach_file Other
attach_file Technology
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Sport
attach_file Economics
attach_file Other
attach_file Economics
attach_file Sport
attach_file Other
attach_file Politics
attach_file Politics
attach_file Other


ID: 2292624273
Add Watch Country

arrow_drop_down